CELGZ

US serial number:85147093
Application filling date:Oct. 07, 2010
Register:Principal
Mark type:Trademark, Service Mark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Jun. 28, 2011
Publication date:Apr. 12, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:60620/2010
Foreign foreign application filling date:Oct. 06, 2010
Foreign foreign registration number:610821
Foreign foreign registration date:Oct. 06, 2010
Foreign foreign application registration country:SWITZERLAND
Foreign foreign expiration date:Oct. 06, 2020
Goods and services:For: Pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses
Current owner owner name:Celgene Corporation
Current owner owner address:86 Morris Avenue Summit, NEW JERSEY UNITED STATES 07901
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Camille M. Miller
Attorney email:cmiller@cozen.com
Attorney docket number:CELG0867CH/2
Attorney email authorized:No
Correspondent name address:CAMILLE M. MILLER COZEN O'CONNOR, PC 1650 MARKET ST One Liberty Place PHILADELPHIA, PENNSYLVANIA UNITED STATES 19103-3508
Correspondent phone:215-665-7273
Correspondent email:cmiller@cozen.com
Correspondent fax:215-701-2273
Correspondent email authorized CELGZ:Yes

Reviews

Required fields are marked *